Skip to main content
. 2018 Dec 25;53(Suppl 1):S76–S87. doi: 10.5152/TurkPediatriArs.2018.01808

Table 5.

Drugs used in treatment of patent ductus arteriosus and their doses

Drug Dose (mg/kg) Route of administration Rate of closure of PDA (%) Adverse effects Reopening (%)
Indomethacin <48 hours IV At least 30 min 70-80 Oliguria, reduction in creatinine clearance, electrolyte imbalance, bleeding in GIS, NEC, perforation 20-35
1st dose: 0.2 mg/ kg 12 hours later 2nd dose: 0.1 mg/kg 24 hours later 3rd dose: 0.1 mg/kg
>48 hours
0.2 mg/kg with 12-24-hour intervals
Ibuprofen Loading: 10 mg/kg with 24-hour intervals IV or oral 70-80 Oliguria, reduction in creatinine clearance, 30
5 mg/kg, 2 successive doses hyperbilirubinemia, bleeding
Paracetamol 15 mg/kg every 6 hours, po Oral or IV 2-7 days 90- 100 Increase in liver enzymes 30

GIS: gastrointestinal system, PDA: patent ductus arteriosus, NEC: necrotizing enterocolitis